Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model.

MLA

Orozco, Johnnie J., et al. “Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model.” PLoS ONE, vol. 9, no. 12, Dec. 2014, pp. 1–17. EBSCOhost, https://doi.org/10.1371/journal.pone.0113601.

APA

Orozco, J. J., Balkin, E. R., Gooley, T. A., Kenoyer, A., Hamlin, D. K., Wilbur, D. S., Fisher, D. R., Hylarides, M. D., Shadman, M., Green, D. J., Gopal, A. K., Press, O. W., & Pagel, J. M. (2014). Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model. PLoS ONE, 9(12), 1–17. https://doi.org/10.1371/journal.pone.0113601

Chicago

Orozco, Johnnie J., Ethan R. Balkin, Ted A. Gooley, Aimee Kenoyer, Donald K. Hamlin, D. Scott Wilbur, Darrell R. Fisher, et al. 2014. “Anti-CD45 Radioimmunotherapy with 90Y but Not 177Lu Is Effective Treatment in a Syngeneic Murine Leukemia Model.” PLoS ONE 9 (12): 1–17. doi:10.1371/journal.pone.0113601.